Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.18.1.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
FL.26NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FL.26NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
EG.8NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EG.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CH.1.1.6NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CH.1.1.6NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.2.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CH.1.1.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CH.1.1.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2.75.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.2.75.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BQ.1.1.66NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BQ.1.1.66NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BN.1.3.12NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BN.1.3.12NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.5.2.20NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.5.2.20NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BQ.1.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BQ.1.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
DV.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
DV.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.4.1.8NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.4.1.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BN.1.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BN.1.3NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BN.1.3.9NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BN.1.3.9NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BQ.1.1.8NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BQ.1.1.8NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
DV.6NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
DV.6NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2 (Omicron)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-2973.23Hong Kong
BA.2 (Omicron)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.5.5.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.5.5.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
CH.1.1.15NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
CH.1.1.15NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BQ.1.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BQ.1.1.19NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BQ.1.1.19NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BN.1.3.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BN.1.3.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.4.6.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.4.6.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.5.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.5.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
BA.2.36NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BA.2.36NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used